Todas as matérias desta categoria, das mais recentes às mais antigas.
Cullinan Therapeutics (NASDAQ:CGEM), Taiho Oncology, and Taiho Pharmaceutical reported that zipalertinib plus chemotherapy improved median progression-free survival by six months versus chemotherapy alone in the Phase 3 REZILIENT3 trial.
Whitehawk Therapeutics (NASDAQ:WHWK) reported WCLC 2026 real-world analyses supporting protein tyrosine kinase 7, or PTK7, as a potential antibody-drug conjugate target in pretreated EGFR wild-type non-small cell lung cancer.
Johnson & Johnson (NYSE:JNJ) reported final Phase 3 PAPILLON results showing median overall survival of 34.3 months with first-line IV RYBREVANT plus carboplatin-pemetrexed versus 27.9 months with chemotherapy alone.
AstraZeneca (NASDAQ:AZN) reported updated Phase III ADAURA results showing TAGRISSO reduced the risk of death by 48% versus placebo after eight years in the overall Stage IB-IIIA EGFR-mutated NSCLC population.
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo reported that ENHERTU achieved median progression-free survival of 14.3 months in the Phase III DESTINY-Lung04 lung cancer trial.
Nanobiotix (NASDAQ:NBTX) reported complete Phase 1 full-cohort results for radiotherapy-activated JNJ-1900, formerly NBTXR3, in 24 patients with inoperable, locoregionally recurrent non-small cell lung cancer eligible for re-irradiation.
Takeda (NYSE:TAK) said the U.S. FDA accepted its New Drug Application for zasocitinib under Priority Review for adults with moderate-to-severe plaque psoriasis.
Novo Nordisk (NYSE:NVO) launched a corporate rebrand that will see the company use the shorter “Novo” name in day-to-day communications while retaining Novo Nordisk A/S as its legal name.
Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade." For up to the minute market intelligence and insight, click MLIV <GO>.
The Federal Reserve faces mounting pressure to hike interest rates this week to tame elevated inflation, putting Chairman Kevin Warsh on a collision course with US President Donald Trump, who has repeatedly pressed the central bank to slash rates. Bloomberg MLIV's Mark Cranfield previews Wednesday's decision, and also what to expect from the Bank of England and Bank of Japan.
UniCredit Chief Executive Officer Andrea Orcel and German Finance Minister Lars Klingbeil are set to meet and "engage in a dialogue" to discuss a potential deal over Commerzbank. The talks mark a clear break from Berlin's previous effort to thwart a transaction that might end up being the largest across global banking in almost two decades. Bloomberg's Steven Arons breaks down the situation.
Oil pushed higher after Saudi Arabia shut a major crude pipeline following attacks, disrupting a route used to bypass the Strait of Hormuz during the US-Iran war. Meanwhile, a planned meeting between Iran and several Gulf nations on creating a temporary shipping lane through the Strait of Hormuz has been postponed. Hasan Alhasan, Senior Fellow for Middle East Policy at the International Institute for Strategic Studies spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East & Africa on the developments in the region.
